There isn’t yet sufficient evidence to show boosters for people under 65 are necessary, said members of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee.
Read more at:
FDA panel recommends Pfizer-BioNTech COVID-19 booster shots only for people 65 and older or at high risk
